- Home
- NDRA vs YHC Comparison
NDRA vs YHC Comparison
Compare NDRA & YHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- YHC
- Stock Information
- Founded
- NDRA 2007
- YHC 2021
- Country
- NDRA United States
- YHC United States
- Employees
- NDRA N/A
- YHC N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- YHC Beverages (Production/Distribution)
- Sector
- NDRA Health Care
- YHC Consumer Staples
- Exchange
- NDRA Nasdaq
- YHC Nasdaq
- Market Cap
- NDRA 2.3M
- YHC 1.9M
- IPO Year
- NDRA 2017
- YHC N/A
- Fundamental
- Price
- NDRA $4.39
- YHC $0.95
- Analyst Decision
- NDRA Strong Buy
- YHC
- Analyst Count
- NDRA 1
- YHC 0
- Target Price
- NDRA $46.00
- YHC N/A
- AVG Volume (30 Days)
- NDRA 63.2K
- YHC 7.1M
- Earning Date
- NDRA 08-14-2025
- YHC 08-12-2025
- Dividend Yield
- NDRA N/A
- YHC N/A
- EPS Growth
- NDRA N/A
- YHC N/A
- EPS
- NDRA N/A
- YHC N/A
- Revenue
- NDRA N/A
- YHC $2,390,517.00
- Revenue This Year
- NDRA N/A
- YHC $69.97
- Revenue Next Year
- NDRA N/A
- YHC $403.29
- P/E Ratio
- NDRA N/A
- YHC N/A
- Revenue Growth
- NDRA N/A
- YHC 31.49
- 52 Week Low
- NDRA $2.90
- YHC $0.86
- 52 Week High
- NDRA $25.90
- YHC $98.00
- Technical
- Relative Strength Index (RSI)
- NDRA 40.24
- YHC 43.37
- Support Level
- NDRA $4.42
- YHC $0.86
- Resistance Level
- NDRA $4.92
- YHC $0.96
- Average True Range (ATR)
- NDRA 0.36
- YHC 0.14
- MACD
- NDRA -0.03
- YHC 0.02
- Stochastic Oscillator
- NDRA 28.88
- YHC 9.49
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About YHC LQR House Inc. Common Stock
LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.